SSA
PROF

Schonfeld Strategic Advisors’s Profound Medical PROF Stock Holding History

Schonfeld Strategic Advisors’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,200
Closed -$95.1K – 2327
2023
Q4 		$95.1K Buy
11,200
+300
+3% +$2.85K ﹤0.01% 1627
2023
Q3 		$111K Buy
10,900
+300
+3% +$3.11K ﹤0.01% 1483
2023
Q2 		$138K Sell
10,600
-100
-0.9% -$1.24K ﹤0.01% 1660
2023
Q1 		$99.4K Sell
10,700
-100
-0.9% -$1.16K ﹤0.01% 1695
2022
Q4 		$118K Sell
10,800
-300
-3% -$1.64K ﹤0.01% 2140
2022
Q3 		$44K Sell
11,100
-100
-0.9% -$675 ﹤0.01% 2656
2022
Q2 		$81K Sell
11,200
-100
-0.9% -$791 ﹤0.01% 2175
2022
Q1 		$102K Sell
11,300
-600
-5% -$5.78K ﹤0.01% 2221
2021
Q4 		$134K Sell
11,900
-100
-0.8% -$1.25K ﹤0.01% 1837
2021
Q3 		$176K Sell
12,000
-200
-2% -$3.05K ﹤0.01% 1806
2021
Q2 		$199K Sell
12,200
-200
-2% -$3.72K ﹤0.01% 1677
2021
Q1 		$250K Buy
+12,400
New +$297K ﹤0.01% 1406

Other funds holding PROF

GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Schonfeld Strategic Advisors's PROF Position: Q1 2024 in Review

Schonfeld Strategic Advisors sold out of Profound Medical (PROF) in Q1 2024, closing a stake of 11,200 shares — an estimated $95.1K sold.

Schonfeld Strategic Advisors first reported a position in PROF in Q1 2021 and held it in 12 quarters. The position peaked at $250K in Q1 2021. 43 funds tracked by Wall St. Rank hold PROF as of Q1 2024.

  • Schonfeld Strategic Advisors reported no remaining Profound Medical position as of Q1 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 11,200 Profound Medical shares in Q1 2024, an estimated $95.1K.
  • Schonfeld Strategic Advisors first reported a position in Profound Medical in Q1 2021 and held it in 12 quarters.
  • Schonfeld Strategic Advisors's Profound Medical position peaked at $250K in Q1 2021.
  • 43 funds tracked by Wall St. Rank held Profound Medical as of Q1 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2024, filed 15 May 2024.